This Week in Cardiology

Weight loss and AF, rotor mapping in AF ablation, repeat AF ablation as a routine strategy, stroke in patients in AF on anticoagulants, and loperamide cardiotoxicity are discussed this week.

VT ablation, racial differences in AF, costs of AF ablation, and medical errors are reviewed in this week's podcast.

ECG screening in athletes, warfarin for AF, sugar-sweetened beverages, CT-induced cancer treatment costs, and night-shift work are the topics discussed by John Mandrola in this week’s podcast.

The FDA’s decision on niacin and fenofibric acid, inappropriate carotid screening, same day discharge PCI, gender differences in testing for CAD, and obesity in adolescents are reviewed this week.

Patient's ICD knowledge, letting pharmacists help manage CV risk, mitral-valve repair with CABG, shared decisions in the ED, and new recommendations on ASA are discussed in this week's podcast.

Dr John Mandrola reviews new ways to think about statin benefits, breast artery calcification, FDA drug surveillance, NOACs before AF ablation, wearable cardiac defibrillators, and ACC2016 in this week's podcast.

Broken-heart syndrome, anticoagulation underuse, polypharmacy in the elderly, hematoma after device implants and new findings in HDL biology are reviewed by Dr John Mandrola in this week's podcast.

Traumatic ICH in elderly on OAC, medical therapy pre-ICD, yoga and AF, e-consultations, bioresorbable stents, and 6 ways to prevent patient deaths are topics discussed by Dr John Mandrola in this week's podcast.

Cancer vs CV death rates, low adherence to OAC drugs, Contrave outcomes, walking to prevent HF, and inaccurate BP apps are reviewed in this week's podcast.

The NBA heart study, MitraClip safety notice, CAC and dementia, RAS blockade in patients with diabetes and hypertension, and lead damage after device generator change are discussed this week.